154 related articles for article (PubMed ID: 37303494)
61. KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancer.
Ren Z; Xu Y; Wang X; Ren M
Environ Sci Pollut Res Int; 2022 Apr; 29(19):28480-28494. PubMed ID: 34993814
[TBL] [Abstract][Full Text] [Related]
62. Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.
Kawami M; Takenaka S; Akai M; Yumoto R; Takano M
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944497
[TBL] [Abstract][Full Text] [Related]
63. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
64. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
65. The Methylation of the p53 Targets the Genes
Voropaeva EN; Pospelova TI; Orlov YL; Churkina MI; Berezina OV; Gurazheva AA; Ageeva TA; Seregina OB; Maksimov VN
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011313
[TBL] [Abstract][Full Text] [Related]
66. Suppressive effect of exogenous miR-16 and miR-34a on tumorigenesis of breast cancer cells.
Haghi M; Taha MF; Javeri A
J Cell Biochem; 2019 Aug; 120(8):13342-13353. PubMed ID: 30916815
[TBL] [Abstract][Full Text] [Related]
67. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling.
Lal A; Thomas MP; Altschuler G; Navarro F; O'Day E; Li XL; Concepcion C; Han YC; Thiery J; Rajani DK; Deutsch A; Hofmann O; Ventura A; Hide W; Lieberman J
PLoS Genet; 2011 Nov; 7(11):e1002363. PubMed ID: 22102825
[TBL] [Abstract][Full Text] [Related]
68. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
69. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
70. Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance.
Ahmed F; Ijaz B; Ahmad Z; Farooq N; Sarwar MB; Husnain T
Phytomedicine; 2020 Mar; 68():153168. PubMed ID: 31982837
[TBL] [Abstract][Full Text] [Related]
71. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
[TBL] [Abstract][Full Text] [Related]
72. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
Said MN; Muawia S; Helal A; Fawzy A; Allam RM; Shafik NF
Exp Mol Pathol; 2021 Dec; 123():104718. PubMed ID: 34752733
[TBL] [Abstract][Full Text] [Related]
73. Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers.
Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Faridová A; Turyna R; Slanař O; Hořínek A; Kohoutová M
Mol Biol Rep; 2022 Mar; 49(3):1955-1971. PubMed ID: 34993725
[TBL] [Abstract][Full Text] [Related]
74. miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention.
Srivastava N; Manvati S; Srivastava A; Pal R; Kalaiarasan P; Chattopadhyay S; Gochhait S; Dua R; Bamezai RN
Breast Cancer Res; 2011 Apr; 13(2):R39. PubMed ID: 21463514
[TBL] [Abstract][Full Text] [Related]
75. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
[TBL] [Abstract][Full Text] [Related]
76. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H
Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432
[TBL] [Abstract][Full Text] [Related]
77. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
[TBL] [Abstract][Full Text] [Related]
79. MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance.
Ghandadi M; Sahebkar A
Curr Pharm Des; 2016; 22(7):933-9. PubMed ID: 26648462
[TBL] [Abstract][Full Text] [Related]
80. Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status.
Sandhu R; Rein J; D'Arcy M; Herschkowitz JI; Hoadley KA; Troester MA
Carcinogenesis; 2014 Nov; 35(11):2567-75. PubMed ID: 25123132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
